1. Adaptive Phage Therapeutics, Inc, 2021. A Phase I/II Study of Bacteriophage Therapy to Evaluate Safety, Tolerability, and Efficacy of Targeted “Personalized” Bacteriophage Treatments in Patients With Bacterial Infection of the Urinary Tract [Internet]. clinicaltrials.gov; [cited 2021 Sep 28]. Report no.: NCT04287478. Available from: 〈https://clinicaltrials.gov/ct2/show/NCT04287478〉.
2. A combination of silver nanoparticles and visible blue light enhances the antibacterial efficacy of ineffective antibiotics against methicillin-resistant Staphylococcus aureus (MRSA);Akram;Ann. Clin. Microbiol. Antimicrob.,2016
3. Antibiotic resistance in wastewater: occurrence and fate of Enterobacteriaceae producers of class A and class C β-lactamases;Amador;J. Environ. Sci. Health Part A Toxic Hazard. Subst. Environ. Eng.,2015
4. Antimicrobial resistance: tackling a crisis for the health and wealth of nations/the Review on Antimicrobial Resistance chaired by Jim O’Neill. [Internet]. Wellcome Collection. [cited 2021 Aug 5]. Available from: 〈https://wellcomecollection.org/works/rdpck35v〉.
5. Antimicrobial resistance [Internet]. [cited 2021 Sep 30]. Available from: 〈https://www.who.int/westernpacific/health-topics/antimicrobial-resistance〉.